Cargando…
Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
We aimed to analyze the expression of cell-cycle regulation markers – minichromosome maintenance protein 2 (MCM2), Ki-67, Cyclin-A and phosphohistone-H3 (PHH3) − in pre-treatment core-biopsy samples of breast carcinomas in correlation with known predictive and prognostic factors. Totally 52 core bio...
Autores principales: | Tőkés, Tímea, Tőkés, Anna-Mária, Szentmártoni, Gyöngyvér, Kiszner, Gergő, Mühl, Dorottya, Molnár, Béla Ákos, Kulka, Janina, Krenács, Tibor, Dank, Magdolna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297700/ https://www.ncbi.nlm.nih.gov/pubmed/31446607 http://dx.doi.org/10.1007/s12253-019-00726-w |
Ejemplares similares
-
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study
por: Tőkés, Tímea, et al.
Publicado: (2015) -
Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016) -
Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
por: Kajáry, Kornélia, et al.
Publicado: (2019) -
Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
por: Ács, Balázs, et al.
Publicado: (2017) -
The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
por: Dank, Magdolna, et al.
Publicado: (2023)